Record Display for the EPA National Library Catalog


Main Title Health assessment document for dichloramethane; review draft.
Author Bayard, S. P. ; Bayliss, D. L. ; Davidson, I. W. F. ; Fowle, III, J. R. ; Greenberg, M.
CORP Author Environmental Protection Agency, Washington, DC. Office of Health and Environmental Assessment.
Publisher USEPA,
Year Published 1983
Report Number EPA 600/8-82-004B
Stock Number PB84-162643
OCLC Number 16678593
Additional Subjects Public health ; Toxicology ; Assessments ; Chloromethanes ; Urban areas ; Physical properties ; Chemical properties ; Transport properties ; Exposure ; Ecology ; Regulations ; Metabolism ; Air pollution ; Water pollution ; Chlorine organic compounds ; Laboratory animals ; Environmental impacts ; Mutagens ; Malignant neoplasms ; Methane/dichloro ; Air pollution effects(Humans) ; Water pollution effects(Humans) ; Toxic substances ; Path of pollutants ; Pharmacokinetics ; Cancer
Internet Access
Description Access URL
Library Call Number Additional Info Location Last
EHAM  TD884.5.H43 1983y Region 1 Library/Boston,MA 04/29/2016
EJBD ARCHIVE EPA 600-8-82-004B Headquarters Library/Washington,DC 11/30/2009
NTIS  PB84-162643 Some EPA libraries have a fiche copy filed under the call number shown. 07/26/2022
Collation 1 volume (various pagings)
Dichloromethane (DCM) is a solvent widely used for a variety of purposes. It has been detected in the ambient air of urban and non-urban areas of the United States and also in natural and municipal waters. The weight of available evidence indicates that adverse toxicologic effects (other than carcinogenicity and mutagenicity) in humans are unlikely to occur at ambient air and water levels found or expected in the general environment. Available evidence suggests that the teratogenic potential of DCM is capable of causing gene mutations and has the potential to cause such effects in exposed human cells. The weight of evidence for carcinogenicity in animals is limited, according to the criteria of the International Agency for Research on Cancer (IARC). However, when the absence of epidemiological evidence is considered, the overall evaluation of DCM, according to IARC criteria, is that it is a Group 3 chemical in that it cannot be classified as to its carcinogenic potential for humans.